Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Utility of FDG-PET in Post Transplant Lymphoproliferative Disorders: An Update from a Single Center Experience

Erika Ravelli, MD, Valentina Mancini, MD, Livio Gargantini, MD, Chiara Rusconi, MD, Claudia Maria Basilico, MD, Mauro Turrini, MD, Vittorio Ruggiero Zilioli, MD, Denis Ciapanna, MD, Giuliana Muti, MD, Claudio Rossetti, MD, Annamaria Nosari, MD, Enrica Morra, MD

Blood (2008) 112 (11): 5266.

https://doi.org/10.1182/blood.V112.11.5266.5266

Published: 2008

Journal Articles

Skeletal Involvement in Advanced Stage Lymphomas: Role of Total Body Magnetic Resonance.

Chiara Rusconi, MD, Erika Ravelli, MD, Livio Gargantini, MD, Francesca Ganguzza, MD, Denis Ciapanna, MD, Cristiana Ticca, MD, Mauro Turrini, MD, Gianbattista Bertani, MD, Angelo Vanzulli, MD, Enrica Morra, MD

Blood (2007) 110 (11): 4405.

https://doi.org/10.1182/blood.V110.11.4405.4405

Published: 2007

Journal Articles

Combined Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC), an Active Regimen for Treated Patients with Chronic Lymphocytic Leukemia (CLL).

Marco Montillo, MD, Sara Miqueleiz, MD, Alessandra Tedeschi, MD, Francesca Ricci, MD, Eleonora Vismara, MD, Denis Ciapanna, MD, Valeria Belsito Petrizzi, MD, Monica Crugnola, MD, Mauro Spriano, MD, Lilj Uziel, MD, Angelo De Blasio, MD, Pierangelo Spedini, PhD, Enrica Morra, MD

Blood (2007) 110 (11): 3133.

https://doi.org/10.1182/blood.V110.11.3133.3133

Published: 2007

Journal Articles

Portal Vein Thrombosis Following Splenectomy for Hematologic Diseases: Prevalence and Risk Factors.

Denis Ciapanna, MD, Annamaria Nosari, MD, Livio Gargantini, MD, Giovanni Mostarda, MD, Michele Nichelatti, MSc, Mauro Turrini, MD, Enrica Morra, MD

Blood (2006) 108 (11): 1498.

https://doi.org/10.1182/blood.V108.11.1498.1498

Published: 2006

Journal Articles

Good Efficacy of Single Dose PEG-Filgrastim in Enhancing the Mobilization of CD34+ Peripheral Blood Stem Cells (PBSC) in Aggressive Lymphoma Patients Treated with Cisplatin-Containing Regimens.

Annamaria Nosari, MD, Claudia Baraté, MD, Liliana Intropido, PhD, Denis Ciapanna, MD, Roberto Cairoli, MD, Livio Gargantini, MD, Laura Pezzetti, PhD, Valentina Mancini, MD, Erica Ravelli, MD, Francesca Ricci, MD, Roberto Ripamonti, PhD, Enrica Morra, MD

Blood (2005) 106 (11): 4265.

https://doi.org/10.1182/blood.V106.11.4265.4265

Published: 2005

NARROW

Utility of FDG-PET in Post Transplant Lymphoproliferative Disorders: An Update from a Single Center Experience

Skeletal Involvement in Advanced Stage Lymphomas: Role of Total Body Magnetic Resonance.

Combined Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC), an Active Regimen for Treated Patients with Chronic Lymphocytic Leukemia (CLL).

Portal Vein Thrombosis Following Splenectomy for Hematologic Diseases: Prevalence and Risk Factors.

Good Efficacy of Single Dose PEG-Filgrastim in Enhancing the Mobilization of CD34+ Peripheral Blood Stem Cells (PBSC) in Aggressive Lymphoma Patients Treated with Cisplatin-Containing Regimens.

Email alerts

ASH Publications

American Society of Hematology

Utility of FDG-PET in Post Transplant Lymphoproliferative Disorders: An Update from a Single Center Experience

Skeletal Involvement in Advanced Stage Lymphomas: Role of Total Body Magnetic Resonance.

Combined Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC), an Active Regimen for Treated Patients with Chronic Lymphocytic Leukemia (CLL).

Portal Vein Thrombosis Following Splenectomy for Hematologic Diseases: Prevalence and Risk Factors.

Good Efficacy of Single Dose PEG-Filgrastim in Enhancing the Mobilization of CD34+ Peripheral Blood Stem Cells (PBSC) in Aggressive Lymphoma Patients Treated with Cisplatin-Containing Regimens.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only